Yelizaveta I Sher, MD
Psychiatry · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Offices
- 3
- Since medical school
- 19 years
- Washington University School of Medicine, 2007
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sher’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A105510 · Current
Licensed to practise in California · since 2008 · expires 2028-03-31 · Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$68,369
Medicare paid this office $68,369 for 179 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $18,778 | $70 |
| Return visit (30+ min) | 38 | $15,774 | $117 |
| Psychotherapy, 45 minutes | 12 | $8,804 | $90 |
| Long return visit (40+ min) | 13 | $5,584 | $169 |
| Psychotherapy, 30 minutes | 28 | $4,800 | $67 |
See all 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $18,778 | $70 |
| Return visit (30+ min) | 38 | $15,774 | $117 |
| Psychotherapy, 45 minutes | 12 | $8,804 | $90 |
| Long return visit (40+ min) | 13 | $5,584 | $169 |
| Psychotherapy, 30 minutes | 28 | $4,800 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,629 | $116 |
| Short return visit (20+ min) | 18 | $2,960 | $78 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,315 | $44 |
Who their Medicare patients are
179 Original Medicare patients in 2024. Average age 65 · Under 65 33% · Women 55% · Also on Medicaid 44% · Health risk score 3.46. Sicker patients than 9 in 10 peers; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 75% · Depression 64% · Chronic kidney disease 50% · Diabetes 47% · Heart failure 45% · COPD 44% · Dementia 42% · Coronary heart disease 41% · Atrial fibrillation 40% · Stroke 22% · Cancer 20%.
The office billed $296,263, Medicare allowed $87,594 and paid $68,369; for 795 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 179 | 795 | 65 | 3.46 | $296,263 | $68,369 |
| 2023 | 166 | 1,023 | 64 | 3.46 | $365,112 | $73,932 |
| 2022 | 173 | 1,067 | 63 | 3.27 | $407,386 | $79,078 |
| 2021 | 139 | 1,025 | 61 | 3.42 | $375,277 | $77,928 |
| 2020 | 136 | 1,074 | 63 | 3.17 | $393,912 | $71,195 |
| 2019 | 153 | 782 | 63 | 3.06 | $249,213 | $57,634 |
| 2018 | 182 | 814 | 64 | 3.31 | $189,531 | $58,078 |
| 2017 | 232 | 918 | 66 | 2.61 | $224,391 | $65,641 |
| 2016 | 270 | 916 | 64 | 2.93 | $236,619 | $67,159 |
| 2015 | 322 | 957 | 63 | 2.50 | $240,131 | $70,367 |
| 2014 | 386 | 1,078 | 64 | 2.46 | $256,873 | $76,894 |
| 2013 | 309 | 803 | 62 | 2.33 | $206,802 | $56,045 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 43 | $16,247 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $15,121 | $73 |
| Long return visit (40+ min) | 25 | $10,515 | $162 |
| Psychotherapy, 45 minutes | 14 | $10,114 | $90 |
| Telehealth originating site facility fee | 59 | $6,917 | $22 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,707 | $120 |
| Short return visit (20+ min) | 18 | $2,632 | $85 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 30 | $2,123 | $45 |
| Psychotherapy, 30 minutes | 12 | $1,889 | $70 |
2022: 9 services
| Return visit (30+ min) | 39 | $15,896 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $14,035 | $94 |
| Psychotherapy, 45 minutes | 12 | $12,987 | $88 |
| Long return visit (40+ min) | 30 | $11,324 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 61 | $7,282 | $65 |
| Telehealth originating site facility fee | 58 | $7,070 | $21 |
| Short return visit (20+ min) | 25 | $2,704 | $75 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 29 | $2,621 | $90 |
| New patient visit (60+ min) | 11 | $2,125 | $193 |
2021: 8 services
| Long return visit (40+ min) | 34 | $17,456 | $171 |
| Return visit (30+ min) | 30 | $14,134 | $124 |
| Psychotherapy, 45 minutes | 12 | $13,772 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $7,923 | $93 |
| Telehealth originating site facility fee | 48 | $7,783 | $21 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $7,237 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 35 | $3,317 | $92 |
| Short return visit (20+ min) | 23 | $2,533 | $79 |
2020: 10 services
| Return visit (30+ min) | 32 | $14,883 | $99 |
| Psychotherapy, 45 minutes | 14 | $8,887 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $8,279 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $8,216 | $97 |
| Short return visit (20+ min) | 33 | $7,262 | $71 |
| Telehealth originating site facility fee | 35 | $6,509 | $21 |
| Psychotherapy with evaluation and management visit, 45 minutes | 15 | $4,876 | $84 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 22 | $2,059 | $94 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $1,155 | $72 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $401 | $36 |
2019: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $16,780 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $6,131 | $93 |
| Return visit (30+ min) | 27 | $5,114 | $93 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 43 | $3,997 | $91 |
| Return visit (30+ min) | 29 | $3,643 | $70 |
| Psychotherapy with evaluation and management visit, 45 minutes | 14 | $3,586 | $80 |
| Short return visit (20+ min) | 21 | $2,723 | $72 |
| Short return visit (20+ min) | 25 | $2,449 | $46 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $746 | $36 |
2018: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 109 | $23,316 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $13,481 | $94 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 56 | $5,030 | $90 |
| Return visit (30+ min) | 26 | $3,518 | $68 |
| Short return visit (20+ min) | 25 | $2,534 | $45 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $909 | $35 |
2017: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 140 | $27,766 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $13,368 | $93 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 79 | $7,536 | $90 |
| Return visit (30+ min) | 24 | $3,598 | $71 |
| Psychotherapy with evaluation and management visit, 45 minutes | 11 | $2,096 | $70 |
| Short return visit (20+ min) | 19 | $2,008 | $45 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,709 | $122 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 33 | $1,502 | $35 |
2016: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 134 | $21,738 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 71 | $15,789 | $91 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 83 | $7,870 | $87 |
| Return visit (30+ min) | 40 | $6,263 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $2,143 | $119 |
| Long return visit (40+ min) | 23 | $2,136 | $93 |
| Psychotherapy with evaluation and management visit, 30 minutes | 16 | $1,819 | $55 |
| Short return visit (20+ min) | 15 | $1,161 | $45 |
| New patient visit (45+ min) | 11 | $1,003 | $91 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $718 | $34 |
2015: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 155 | $28,126 | $65 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 104 | $9,643 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $8,662 | $93 |
| Return visit (30+ min) | 56 | $7,009 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,629 | $122 |
| Psychotherapy with evaluation and management visit, 30 minutes | 16 | $1,677 | $52 |
| New patient visit (45+ min) | 12 | $1,385 | $115 |
| Short return visit (20+ min) | 17 | $1,050 | $42 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $487 | $35 |
2014: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 193 | $28,584 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 75 | $9,018 | $120 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 97 | $8,748 | $89 |
| Return visit (30+ min) | 55 | $6,559 | $69 |
| Psychotherapy with evaluation and management visit, 30 minutes | 20 | $4,330 | $57 |
| Short return visit (20+ min) | 33 | $4,233 | $44 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $2,957 | $92 |
| New patient visit (60+ min) | 16 | $2,278 | $142 |
| New patient visit (45+ min) | 16 | $1,850 | $116 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 40 | $1,666 | $35 |
2013: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 140 | $19,456 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 123 | $15,204 | $119 |
| Return visit (30+ min) | 49 | $4,890 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,232 | $90 |
| New patient visit (45+ min) | 17 | $1,930 | $114 |
| New patient visit (60+ min) | 14 | $1,917 | $137 |
| Psychotherapy with evaluation and management visit, 30 minutes | 20 | $1,824 | $28 |
| Short return visit (20+ min) | 25 | $1,702 | $36 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,656 | $87 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $537 | $34 |
Medicaid work
$1,164 in 2024
Medicaid paid $1,164 for 53 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 53 | $1,164 |
| 2024 | 53 | 1 | 12 | $1,164 |
Drugs they prescribed that Part D paid
$27,028
Pharmacies billed $27,028 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 744) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
712 generic and 32 brand-name prescriptions · $27,028 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trintellix | 29 | $15,411 | $531 |
| Bupropion Xl | 78 | $1,790 | $23 |
| Pregabalin | 68 | $1,195 | $18 |
| Hydroxyzine | 53 | $1,098 | $21 |
| Mirtazapine | 54 | $609 | $11 |
See all 22 drugs
| Trintellix | 29 | $15,411 | $531 |
| Bupropion Xl | 78 | $1,790 | $23 |
| Pregabalin | 68 | $1,195 | $18 |
| Hydroxyzine | 53 | $1,098 | $21 |
| Mirtazapine | 54 | $609 | $11 |
| Ziprasidone | 24 | $594 | $25 |
| Modafinil | 14 | $556 | $40 |
| Escitalopram | 63 | $438 | $7 |
| Divalproex Sodium Er | 34 | $400 | $12 |
| Fluoxetine | 30 | $363 | $12 |
| Methylphenidate | 14 | $273 | $20 |
| Gabapentin | 12 | $254 | $21 |
| Lorazepam | 30 | $244 | $8 |
| Bupropion Hcl Sr | 12 | $241 | $20 |
| Sertraline | 28 | $216 | $8 |
| Lithium Carbonate Er | 21 | $215 | $10 |
| Trazodone | 21 | $190 | $9 |
| Duloxetine | 15 | $175 | $12 |
| Guanfacine | 14 | $87 | $6 |
| Clonazepam | 23 | $81 | $4 |
| Zolpidem | 20 | $48 | $2 |
| Citalopram Hbr | 14 | $40 | $3 |
Year by year
| 2024 | 744 | 57 | 0% (0) | 4% | $27,028 |
| 2023 | 751 | 54 | 0% (0) | 5% | $38,621 |
| 2022 | 642 | 53 | 0% (0) | None | $20,615 |
| 2021 | 735 | 49 | 0% (0) | 5% | $29,467 |
| 2020 | 586 | 44 | 0% (0) | 7% | $23,566 |
| 2019 | 562 | 48 | 0% (0) | 5% | $20,470 |
| 2018 | 650 | 47 | None | None | $20,888 |
| 2017 | 474 | 48 | 0% (0) | 6% | $19,240 |
| 2016 | 458 | 45 | 0% (0) | 4% | $25,592 |
| 2015 | 505 | 62 | 0% (0) | None | $17,696 |
| 2014 | 417 | 47 | None | 6% | $21,734 |
| 2013 | 242 | 37 | 0% (0) | 11% | $10,103 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Trintellix | 15 | $7,552 | $503 |
| Bupropion Xl | 97 | $2,950 | $30 |
| Aripiprazole | 20 | $2,629 | $131 |
| Hydroxyzine | 40 | $1,488 | $37 |
| Fluoxetine | 18 | $1,447 | $80 |
| Duloxetine | 42 | $1,363 | $32 |
| Olanzapine | 18 | $1,344 | $75 |
| Escitalopram | 65 | $939 | $14 |
| Mirtazapine | 50 | $915 | $18 |
| Sertraline | 46 | $904 | $20 |
| Guanfacine | 22 | $634 | $29 |
| Pregabalin | 39 | $613 | $16 |
| Divalproex Sodium Er | 27 | $586 | $22 |
| Ziprasidone | 12 | $583 | $49 |
| Methylphenidate | 16 | $357 | $22 |
| Divalproex | 12 | $356 | $30 |
| Lorazepam | 30 | $280 | $9 |
| Trazodone | 27 | $279 | $10 |
| Buspirone | 13 | $237 | $18 |
| Gabapentin | 11 | $217 | $20 |
| Clonazepam | 18 | $182 | $10 |
| Lithium Carbonate Er | 15 | $158 | $11 |
| Zolpidem | 16 | $47 | $3 |
2022: 18 drugs
| Doxepin | 12 | $2,978 | $248 |
| Bupropion Xl | 75 | $2,731 | $36 |
| Hydroxyzine | 64 | $1,914 | $30 |
| Fluoxetine | 15 | $1,579 | $105 |
| Aripiprazole | 18 | $1,398 | $78 |
| Mirtazapine | 46 | $850 | $18 |
| Escitalopram | 80 | $803 | $10 |
| Sertraline | 75 | $786 | $10 |
| Venlafaxine Hcl Er | 18 | $514 | $29 |
| Duloxetine | 34 | $502 | $15 |
| Pregabalin | 27 | $430 | $16 |
| Divalproex Sodium Er | 18 | $355 | $20 |
| Gabapentin | 16 | $306 | $19 |
| Lorazepam | 25 | $166 | $7 |
| Zolpidem | 15 | $105 | $7 |
| Trazodone | 17 | $76 | $4 |
| Clonazepam | 12 | $33 | $3 |
| Citalopram Hbr | 12 | $19 | $2 |
2021: 20 drugs
| Trintellix | 13 | $5,430 | $418 |
| Bupropion Xl | 86 | $3,810 | $44 |
| Mirtazapine | 70 | $1,601 | $23 |
| Hydroxyzine | 86 | $1,007 | $12 |
| Escitalopram | 87 | $1,003 | $12 |
| Dextroamphetamine-Amphet Er | 11 | $690 | $63 |
| Duloxetine | 33 | $652 | $20 |
| Aripiprazole | 12 | $414 | $34 |
| Sertraline | 36 | $396 | $11 |
| Gabapentin | 27 | $338 | $13 |
| Pregabalin | 14 | $287 | $21 |
| Venlafaxine Hcl Er | 18 | $282 | $16 |
| Bupropion Hcl Sr | 20 | $273 | $14 |
| Lamotrigine | 20 | $243 | $12 |
| Lorazepam | 27 | $167 | $6 |
| Trazodone | 29 | $141 | $5 |
| Zolpidem | 12 | $127 | $11 |
| Alprazolam | 11 | $104 | $9 |
| Clonazepam | 13 | $63 | $5 |
| Citalopram Hbr | 13 | $29 | $2 |
2020: 12 drugs
| Bupropion Xl | 69 | $2,952 | $43 |
| Mirtazapine | 77 | $1,076 | $14 |
| Hydroxyzine | 66 | $893 | $14 |
| Duloxetine | 39 | $839 | $22 |
| Escitalopram | 52 | $486 | $9 |
| Bupropion Hcl Sr | 31 | $446 | $14 |
| Gabapentin | 18 | $387 | $21 |
| Sertraline | 40 | $364 | $9 |
| Lamotrigine | 18 | $289 | $16 |
| Trazodone | 35 | $198 | $6 |
| Buspirone | 14 | $179 | $13 |
| Lorazepam | 21 | $144 | $7 |
2019: 17 drugs
| Viibryd | 14 | $3,847 | $275 |
| Bupropion Xl | 39 | $1,591 | $41 |
| Mirtazapine | 110 | $1,222 | $11 |
| Bupropion Hcl Sr | 24 | $1,210 | $50 |
| Escitalopram | 50 | $1,063 | $21 |
| Duloxetine | 30 | $873 | $29 |
| Guanfacine Hcl Er | 11 | $816 | $74 |
| Hydroxyzine | 41 | $484 | $12 |
| Zolpidem Tartrate Er | 11 | $395 | $36 |
| Trazodone | 38 | $372 | $10 |
| Gabapentin | 28 | $316 | $11 |
| Buspirone | 20 | $281 | $14 |
| Lamotrigine | 19 | $164 | $9 |
| Sertraline | 20 | $128 | $6 |
| Clonazepam | 14 | $106 | $8 |
| Venlafaxine Hcl Er | 14 | $100 | $7 |
| Lorazepam | 12 | $75 | $6 |
2018: 19 drugs
| Aripiprazole | 12 | $4,362 | $364 |
| Bupropion Xl | 60 | $2,474 | $41 |
| Hydroxyzine | 50 | $1,698 | $34 |
| Bupropion Hcl Sr | 44 | $1,367 | $31 |
| Escitalopram | 56 | $1,199 | $21 |
| Guanfacine Hcl Er | 12 | $1,121 | $93 |
| Duloxetine | 20 | $982 | $49 |
| Mirtazapine | 91 | $950 | $10 |
| Quetiapine | 25 | $741 | $30 |
| Gabapentin | 41 | $411 | $10 |
| Buspirone | 19 | $296 | $16 |
| Trazodone | 33 | $235 | $7 |
| Zolpidem | 19 | $211 | $11 |
| Venlafaxine Hcl Er | 33 | $210 | $6 |
| Lorazepam | 21 | $103 | $5 |
| Lamotrigine | 11 | $87 | $8 |
| Olanzapine | 11 | $81 | $7 |
| Sertraline | 11 | $57 | $5 |
| Clonazepam | 20 | $35 | $2 |
2017: 12 drugs
| Duloxetine | 32 | $1,573 | $49 |
| Bupropion Xl | 33 | $1,167 | $35 |
| Hydroxyzine | 38 | $1,017 | $27 |
| Mirtazapine | 67 | $716 | $11 |
| Bupropion Hcl Sr | 40 | $655 | $16 |
| Escitalopram | 35 | $447 | $13 |
| Gabapentin | 26 | $327 | $13 |
| Trazodone | 32 | $211 | $7 |
| Venlafaxine Hcl Er | 24 | $174 | $7 |
| Sertraline | 20 | $111 | $6 |
| Buspirone | 12 | $106 | $9 |
| Clonazepam | 24 | $106 | $4 |
2016: 13 drugs
| Duloxetine | 45 | $2,381 | $53 |
| Bupropion Hcl Sr | 64 | $1,943 | $30 |
| Bupropion Xl | 33 | $1,300 | $39 |
| Mirtazapine | 69 | $1,239 | $18 |
| Venlafaxine Hcl Er | 18 | $1,088 | $60 |
| Gabapentin | 46 | $673 | $15 |
| Escitalopram | 16 | $281 | $18 |
| Trazodone | 29 | $219 | $8 |
| Clonazepam | 22 | $88 | $4 |
| Citalopram Hbr | 20 | $87 | $4 |
| Olanzapine | 11 | $85 | $8 |
| Lorazepam | 12 | $85 | $7 |
| Sertraline | 11 | $48 | $4 |
2015: 14 drugs
| Duloxetine | 43 | $5,444 | $127 |
| Mirtazapine | 86 | $2,143 | $25 |
| Bupropion Hcl Sr | 84 | $1,472 | $18 |
| Zolpidem Tartrate Er | 13 | $1,099 | $85 |
| Gabapentin | 40 | $681 | $17 |
| Bupropion Xl | 13 | $585 | $45 |
| Venlafaxine Hcl Er | 24 | $314 | $13 |
| Doxepin | 11 | $235 | $21 |
| Escitalopram | 18 | $178 | $10 |
| Trazodone | 27 | $124 | $5 |
| Citalopram Hbr | 30 | $120 | $4 |
| Lorazepam | 16 | $109 | $7 |
| Clonazepam | 22 | $86 | $4 |
| Zolpidem | 11 | $17 | $2 |
2014: 12 drugs
| Duloxetine | 18 | $4,059 | $225 |
| Bupropion Hcl Sr | 34 | $1,472 | $43 |
| Mirtazapine | 90 | $1,334 | $15 |
| Olanzapine | 12 | $1,236 | $103 |
| Bupropion Xl | 23 | $916 | $40 |
| Escitalopram | 35 | $528 | $15 |
| Zolpidem | 32 | $335 | $10 |
| Fluoxetine | 14 | $185 | $13 |
| Citalopram Hbr | 30 | $178 | $6 |
| Gabapentin | 13 | $122 | $9 |
| Clonazepam | 25 | $102 | $4 |
| Trazodone | 20 | $85 | $4 |
2013: 6 drugs
| Bupropion Hcl Sr | 20 | $1,014 | $51 |
| Mirtazapine | 85 | $866 | $10 |
| Sertraline | 21 | $185 | $9 |
| Citalopram Hbr | 16 | $140 | $9 |
| Trazodone | 14 | $75 | $5 |
| Clonazepam | 13 | $58 | $4 |
Money from drug and device companies
$113 in 2024
| 2024 | 1 | 1 | None | $113 |
| 2023 | 1 | 1 | None | $131 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ceribell | Pocket Eeg Device | $113 | 1 payment
|
See the published payment
| Ceribell | Meals · 2024-01-16 | Pocket Eeg Device | $113 |
See earlier years (2023)
2023: $131
| Ceribell | Ceribell Rapid Response Eeg | $131 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1336336965
- Licence
- CA A105510California A105510: Current · expires 2028-03-31
- Trained
- Washington University School of Medicine, 2007 · 19 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2084P0015X (2084P0015X)
- Mailing address
- 1153 Shelter Creek Ln, San Bruno, CA, 94066
- NPI first listed
- 2007-09-27
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 401 Quarry Road, Stanford, CA, 94305